A technician inspects anti-cancer drugs in vials at a lab of a pharmaceutical company in Lianyungang, China March 13, 2019. (China Stringer Network/Reuters) With suspicions growing over a possible lab leak tied to the coronavirus pandemic, China’s startling lab-safety record merits close examination.
NRPLUS MEMBER ARTICLE ‘W hile there is always some risk for lab accidents, risk is not reality.” — Lim Poh Lian, senior consultant at the National Centre for Infectious Diseases in Singapore, to National Public Radio, April 23, 2020.
2004: In the aftermath of a small outbreak of the original SARS virus, well after the main outbreak that ended in summer 2003, a WHO investigation concluded that the Beijing Centers for Disease Control made critical errors in handling samples of the virus. “The patient was allowed to travel between Beijing and her home province of Anhui, to the west of Shanghai, while sick . . …
Continue reading on National Review